Recurrence of type 1 diabetes (T1DR) after simultaneous pancreas-kidney (SPK) transplantation is associated with islet cell autoantibody conversion

被引:0
|
作者
Diamantopoulos, S. [1 ]
Allende, G. [1 ]
Martin-Pagola, A. [1 ]
Ciancio, G. [1 ]
Ricordi, C. [1 ]
Messinger, S. [1 ]
Burke, G. W. [1 ]
Pugliese, A. [1 ]
机构
[1] Univ Miami, Miami, FL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S12 / S12
页数:1
相关论文
共 50 条
  • [1] Autoantibody Conversion Is a Risk Factor for Recurrence of Type 1 Diabetes (T1DR) after Simultaneous Pancreas-Kidney (SPK) Transplantation
    Diamantopoulos, Stavros
    Allende, Gloria
    Ciancio, Gaetano
    Sageshima, Junichiro
    Chen, Linda
    Pugliese, Alberto
    Burke, George W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 6 - 6
  • [2] Autoantibody Conversion Is a Risk Factor for Recurrence of Type 1 Diabetes (T1DR) after Simultaneous Pancreas-Kidney (SPK) Transplantation.
    Burke, George W.
    Ciancio, Gaetano
    Diamantopoulos, Stavros
    Allende, Gloria
    Sageshima, Junichiro
    Chen, Linda
    Ricordi, Camillo
    Messinger, Shari
    Pugliese, Alberto
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 90 - 90
  • [3] Combined B and T Cell-Directed Immunotherapy in Simultaneous Pancreas-Kidney (SPK) Recipients with Recurrence of Type 1 Diabetes (T1DR)
    Burke, George W.
    Reijonen, Helena
    Ciancio, Gaetano
    Sageshima, Junichiro
    Chen, Linda
    Allende, Gloria
    Nepom, Gerald
    Pugliese, Alberto
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 548 - 548
  • [4] Retransplantation of the pancreas in a patient with type 1 diabetes (T1D) following simultaneous pancreas-kidney (SPK) transplantation and recurrence of type I diabetes (T1DR): The role of peri-pancreas transplant lymph nodes
    Burke, G. W.
    Ciancio, G.
    Sageshima, J.
    Rosen, A.
    Allende, G.
    Laughlin, E.
    Pugliese, A.
    Reijonen, H.
    Nepom, G.
    ACTA DIABETOLOGICA, 2007, 44 : S6 - S6
  • [5] Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation
    Burke G.W.
    Ciancio G.
    Morsi M.
    Figueiro J.
    Chen L.
    Vendrame F.
    Pugliese A.
    Current Transplantation Reports, 2018, 5 (4) : 295 - 303
  • [6] HLA-DR3/4 heterozygosity is a risk factor for autoantibody conversion and type 1 diabetes recurrence after simultaneous pancreas-kidney transplantation
    Diamantopoulos, Stavros
    Allende, Gloria
    Burke, George W.
    Ciancio, Gaetano
    Pugliese, Alberto
    CLINICAL IMMUNOLOGY, 2007, 123 : S22 - S22
  • [7] Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation
    Lohmann, T
    Klemm, T
    Geissler, F
    Uhlmann, D
    Ludwig, S
    Hauss, J
    Witzigmann, H
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2249 - 2250
  • [8] Simultaneous pancreas-kidney transplantation in type 1 diabetes
    Morath, C.
    Schmied, B.
    Mehrabi, A.
    Weitz, J.
    Schmidt, J.
    Werner, J.
    Buchler, M. W.
    Morcos, M.
    Nawroth, P. P.
    Schwenger, V.
    Doehler, B.
    Opelz, G.
    Zeier, M.
    CLINICAL TRANSPLANTATION, 2009, 23 : 115 - 120
  • [9] CONVERSION FROM A CALCINEURIN INHIBITOR TO EVEROLIMUS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPK)
    Schenker, P.
    Klein, T.
    Wunsch, A.
    Teodoridis, A.
    Oeztuerk, A.
    Jazra, M.
    Viebahn, R.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 16 - 16
  • [10] Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation in the Absence of GAD and IA-2 Autoantibodies
    Assalino, M.
    Genevay, M.
    Morel, P.
    Demuylder-Mischler, S.
    Toso, C.
    Berney, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (02) : 492 - 495